16-Year Immunization Visit

Every 16-year immunization visit should include:

  • Administration of the second dose of the MenACWY (quadrivalent meningococcal conjugate vaccine)
  • Administration of the influenza vaccine, which is recommended annually (for each influenza season)
  • A discussion about MenB vaccine, which helps to protect against a fifth type of meningococcal bacteria
  • Catch-up for the HPV series, if indicated, which is recommended to be completed by age 11–12 years of age
  • Catch-up for the Tdap booster, if indicated, which is also recommended for all eligible adolescents aged 11–12 years of age

The 16-year-old adolescent immunization platform is supported by a number of professional medical societies, including the Immunization Action Coalition, American Academy of Family Physicians, National Foundation for Infectious Diseases, and Society for Adolescent Health and Medicine, among others.

The Adolescent Immunization Initiative developed a rationale for a 16-year-old immunization platform in the form of a white paper, which is linked for your convenience.


Brought to you as a public health service by the National Meningitis Association, Inc. (NMA) and Sanofi Pasteur Inc. The NMA does not endorse specific products or brands.